Predictions
Carbylan Therapeutics Inc
Start price
Target price
Perf. (%)
€8.10
27.06.23
27.06.23
€12.00
31.07.26
31.07.26
74.07%
04.02.24
04.02.24
Could be very worthwhile Investment >20% year
Carbylan Therapeutics Inc
Start price
Target price
Perf. (%)
€6.60
03.01.23
03.01.23
€10.00
31.12.25
31.12.25
30.22%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.29
06.03.23
06.03.23
-
06.03.24
06.03.24
-13.18%
17.03.23
17.03.23
Risky Investment
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.16
27.09.22
27.09.22
-
27.09.23
27.09.23
-4.31%
01.10.22
01.10.22
Risky Investment
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.42
08.07.21
08.07.21
-
08.07.22
08.07.22
-55.26%
21.05.22
21.05.22
BHP Group plc
Start price
Target price
Perf. (%)
€25.45
14.12.21
14.12.21
€33.00
14.06.22
14.06.22
13.16%
18.05.22
18.05.22
Could be worthwhile Investment >10% per year
Very high dividend yield expected
Undervalued
Higher EBIT margin than peer group
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.02
09.01.22
09.01.22
-
09.01.23
09.01.23
-18.54%
23.01.22
23.01.22
Could be very worthwhile Investment >20% year
Zeal Network SE
Start price
Target price
Perf. (%)
€40.10
09.01.21
09.01.21
€35.00
09.01.22
09.01.22
-2.12%
10.01.22
10.01.22
Top 10 in its market
Probably not worthwhile Investment
Low dividend yield expected
High valuation
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.54
03.01.22
03.01.22
-
03.01.23
03.01.23
-14.69%
09.01.22
09.01.22
Risky Investment
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.26
12.12.21
12.12.21
-
12.12.22
12.12.22
9.82%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
BHP Group plc
Start price
Target price
Perf. (%)
€21.63
18.12.20
18.12.20
€26.00
18.12.21
18.12.21
17.66%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Very high dividend yield expected
Undervalued
Higher EBIT margin than peer group
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.28
02.12.21
02.12.21
-
02.12.22
02.12.22
-0.61%
11.12.21
11.12.21
Risky Investment
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€4.48
14.09.21
14.09.21
-
14.09.22
14.09.22
-4.46%
19.09.21
19.09.21
Risky Investment
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€5.70
18.10.20
18.10.20
€2.00
04.11.21
04.11.21
-35.79%
26.06.21
26.06.21
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€4.04
02.04.19
02.04.19
€4.51
30.10.19
30.10.19
-80.57%
30.10.19
30.10.19
Akari Therapeutics plc ADR
Start price
Target price
Perf. (%)
€4.33
19.03.19
19.03.19
€8.12
10.04.19
10.04.19
-28.75%
10.04.19
10.04.19